Open Accessibility Menu
Hide

Meet the 3D Ultrasound/MRI Fusion Biopsy Specialists

Daniel D. Dietrick

Daniel D. Dietrick, M.D., F.A.C.S.

Curriculum Vitae

American Board of Urology;
Fellow of the American College of Surgeons

  • University of Maryland College Park, B.A.
  • Johns Hopkins School of Medicine, M.D.
  • Stanford University Medical Center General Surgery Residency
  • Stanford University Medical Center Urology Residency
  • Chief Value Officer, Chesapeake Urology Associates, LLC
  • President, Medical Staff, University of Maryland St. Joseph Medical Center
  • Associate Professor of Surgery, University of Maryland St. Joseph Medical Center

Dr. Dietrick specializes in the treatment of prostate cancer, including da Vinci robot-assisted laparoscopic radical prostatectomy. In addition, his focus includes medical and minimally invasive treatment of enlarged prostate (BPH) and voiding problems in men. Dr. Dietrick also performs the UroLift procedure for the treatment of BPH/enlarged prostate.

His interest in cancer treatment began in the 1980s with work at the National Cancer Institute and continued through his years on the clinical faculty of Stanford Medical Center and the Johns Hopkins University Department of Urology. Dr. Dietrick performed the first da Vinci robotic prostatectomy at a community hospital in Maryland in 2005 and has performed approximately 1,000 successful operations since then, more than any other community urologist in Maryland. Dr. Dietrick performed traditional open prostatectomies for 15 years prior to this.

Baltimore Magazine 2017 Top Doctor AwardDr. Dietrick served as Prostate Chair of the Maryland Chapter of the American Cancer Society, was awarded one of the first Young Leaders in Urology awards of the American Urological Association, and is a member of the American Association of Physician Leaders. He served as Chief of the Department of Surgery, St. Joseph Medical Center for 8 years and is now the President of the Medical Staff. In addition, he has led and served on many quality improvement teams, medical boards and executive boards at several local hospitals..

In 2010, he was inducted into The Healing Hands Guild of the University of Maryland St. Joseph Medical Center. The Guild honors physicians who excel in their clinical skills and demonstrate an unwavering commitment to excellent and compassionate care. Dr. Dietrick has also been selected as a Super Doctor in The Washington Post magazine in 2011, 2012 and 2013 and a "Top Doctor" in Baltimore magazine, 2017.

He was named the Chief Value Officer at Chesapeake Urology in 2016, a newly created senior position that is unique among urology groups in the nation. In this position, he will work to develop policies and procedures that produce high quality, cost effective, medical care with measurable outcomes.

Location:

Towson
Physicians Pavilion North, GBMC Campus/Tulip Park
6535 N. Charles Street, Suite 500
Towson, MD 21204
Office: 410-825-5454
Fax: 410-825-5811

Rian J. Dickstein, M.D., F.A.C.S.

Rian J. Dickstein, M.D., F.A.C.S.

Curriculum Vitae

American Board of Urology

  • The University of Texas MD Anderson Cancer Center, Urologic Oncology Fellowship
  • Boston Medical Center (Boston University), Urology Residency
  • Boston Medical Center (Boston University), General Surgery Internship
  • Robert Wood Johnson Medical School, University of Medicine and Dentistry of New Jersey, M.D.
  • Rutgers University, B.A.
  • Director, Bladder Cancer Program, Chesapeake Urology
  • Chief of Urology, University of Maryland Baltimore Washington Medical Center
  • Cancer Liaison Physician for the Tate Cancer Center at The University of Maryland Baltimore Washington Medical Center​
  • Clinical Assistant Professor - Department of Surgery at University of Maryland School of Medicine

Dr. Dickstein is a urologic oncologist who trained at the world-renowned MD Anderson Cancer Center in Houston, Texas. Dr. Dickstein focuses on all urologic cancers and specializes in open, laparoscopic and robotic surgeries. His expertise includes the treatment of bladder cancer (non-invasive and locally advanced), kidney cancer (small or locally advanced tumors), and prostate cancer (including primary and salvage surgery for complex cases).

Dr. Dickstein also specializes in the treatment of testicular and penile cancers. He has published numerous articles on urologic cancers in multiple medical journals and has presented at national meetings on subjects primarily related to bladder and penile cancers.

He is a member of the Bladder Cancer Advocacy Network (BCAN) Scientific Advisory Board, which is composed of distinguished leading academic urologists, oncologists, radiation oncologists, and pathologists working within the bladder cancer field, representing many of the major cancer centers in the U.S and Canada.

Dr. Dickstein received a Merit Award for the 2011 Genitourinary Cancers Symposium by the American Society of Clinical Oncology, was a first place winner of the Max K. Willscher Resident Research Award competition at the New England Section of the American Urological Association, and he was presented with the Editor's Award of Excellence for an Original Study from the Uro Today International Journal.

Dr. Dickstein was inducted into the Alpha Omega Alpha Honor Medical Society while he was in medical school.

Location:

Hanover
7580 Buckingham Blvd.
Suite 100, 101
Hanover, MD 21076

Office: 410-760-9400
Fax: 410-787-1911

Richard M. Levin

Richard M. Levin, M.D., F.A.C.S., C.P.I

Curriculum Vitae

American Board of Urology;
Fellow of the American College of Surgeons;
Certified Principal Investigator

  • University of Pennsylvania, B.S., Cum Laude
  • Emory University School of Medicine, M.D.
  • University of Colorado Health Sciences Center Urology Residency
  • Leicester General Hospital - Leicester, England, Urology Exchange Rotation

VIDEO: DR. LEVIN DISCUSSES REZŪM® FOR THE TREATMENT OF BPH

Dr. Levin has been in the private practice of urology since 1995. His special interests include minimally invasive treatments for prostate cancer including high intensity focused ultrasound (HIFU) and brachytherapy, stone disease and minimally invasive treatment for benign prostatic hyperplasia (BPH), including Rezūm®.

Dr. Levin participated in the clinical trial evaluating the Rezūm® System to treat BPH/enlarged prostate as part of the Rezūm II clinical study. He is one of only a few urologists in the Mid-Atlantic region currently offering this treatment, which is a new treatment option in the BPH clinical continuum of care. The system received FDA 510(k) clearance in September 2015 for treatment of BPH. The Rezūm System is based on the Convective Water Vapor Energy (WAVE™) technology platform to treat a variety of endourological conditions beginning with BPH. The system uses radiofrequency energy to create sterile water vapor, or steam, to convectively deliver targeted, precise thermal energy treatments in a simple procedure with minimal discomfort, and provide improvements in urine flow and quality of life.

Dr. Levin was one of several authors of: PII-LBA1 Using the Thermal Energy of Convectively Delivered Water Vapor for the Treatment of Lower Urinary Tract Symptoms Due to Benign Prostatic Hyperplasia: The Rezum II Study, published in the Journal of Urology (J. of Urology), April 2016.

A member of the American Urological Association, the American Medical Association, and a fellow of the American College of Surgeons, Dr. Levin authored a chapter in Haskells Cancer Treatment on bladder, ureteral and renal pelvic malignancies.

In 2018, Dr. Levin passed the Certified Principal Investigator exam for clinical research trials.

Location:

Towson
Physicians Pavilion North, GBMC Campus/Tulip Park
6535 N. Charles Street, Suite 500
Towson, MD 21204

Office: 410-825-5454
Fax: 410-825-5811

Benjamin H. Lowentritt

Benjamin H. Lowentritt, M.D., F.A.C.S.

Curriculum Vitae

American Board of Urology;
Fellow of the American College of Surgeons

  • Harvard College, A.B., History of Science, Magna Cum Laude
  • Baylor College of Medicine, M.D.
  • University of Maryland Medical System General Surgery Residency
  • University of Maryland Medical System Urology Residency
  • Tulane University Medical Center Fellowship in robotic, laparoscopic, and advanced endoscopic urology
  • Director, Minimally Invasive Surgery and Robotics, Chesapeake Urology Associates
  • Director, Prostate Cancer Care Program, Chesapeake Urology Associates
  • Past President, Baltimore City Medical Society

2017 top doctorDr. Lowentritt has a general urology practice with a focus on minimally invasive techniques to treat urological conditions. His expertise includes robotic, laparoscopic, and endoscopic management of renal, bladder, and prostate cancer, as well as minimally invasive options for benign prostatic hyperplasia (BPH), kidney stones, pelvic organ prolapse, and ureteropelvic junction obstruction.

Dr. Lowentritt has been at the forefront of robotic urology procedures and was the first surgeon in Maryland to perform robot assisted surgery for bladder cancer.

He has authored numerous articles and chapters on subjects including robotic surgery, erectile dysfunction, pediatric urology, female urology and the urological management of patients after renal transplantation.

Dr. Lowentritt has been selected as a "Super Doctor" by his peers in The Washington Post magazine and as a "Top Doctor" in Baltimore magazine numerous times. Dr. Lowentritt serves on the Board of Directors for the Baltimore City Medical Society.

Location:

Towson
Physicians Pavilion North, GBMC Campus/Tulip Park
6535 N. Charles Street, Suite 500
Towson, MD 21204

Office: 410-825-5454
Fax: 410-825-5811

David Stamfer

David S. Stampfer, M.D., F.A.C.S.

Curriculum Vitae

American Board of Urology;
Fellow of the American College of Surgeons

  • Columbia College, Columbia University, B.A., Summa Cum Laude
  • University of Pennsylvania School of Medicine, M.D.
  • Massachusetts General Hospital Surgery Residency Program
  • Massachusetts General Hospital-Harvard Program in Urology

Dr. Stampfer was nationally recognized as a Pfizer Scholar in Urology and served as an Instructor in Surgery at Harvard Medical School.

In practice since 1998, he was featured in CRC's "Guide to America's Top Urologists." Affiliated with St. Joseph Medical Center and GBMC, his interests include renal cell carcinoma, prostate cancer including brachytherapy, kidney stones and benign prostatic hyperplasia (BPH). He also performs the UroLift procedure for the treatment of BPH/enlarged prostate.

Location:

Towson
Physicians Pavilion North, GBMC Campus/Tulip Park
6535 N. Charles Street, Suite 500
Towson, MD 21204

Office: 410-825-5454
Fax: 410-825-5811

Ronald F. Tutrone

Ronald F. Tutrone, JR., M.D., F.A.C.S., C.P.I.

Curriculum Vitae

American Board of Urology;
Fellow of the American College of Surgeons

  • Holy Cross College, B.S.
  • Rutgers University Medical School, M.D.
  • Harvard Medical School Urology Program - Brigham and Women's Hospital
  • Certified Principle Investigator
  • Chief, Division of Urology, Greater Baltimore Medical Center
  • Medical Director, Chesapeake Urology Research Associates
  • Medical Director, Chesapeake Urology Infusion Therapy Center

2017 top doctorDr. Tutrone's clinical interests include treatment of urologic malignancies including kidney, bladder and prostate; laparoscopic treatment of renal and adrenal tumors; kidney stone treatment; urinary incontinence in men and women; and prostate disorders. He also performs the UroLift procedure for the treatment of BPH/enlarged prostate.

He has been voted a "Top Doctor" by Baltimore magazine numerous times, and a "Super Doctor" for Urology in the Washington Post Magazine Washington, DC, Northern Virginia and Baltimore.

Dr. Tutrone has authored numerous articles in the urology literature. He has been principal investigator in more than 200 clinical research trials. He is Chairman of the William E. Kalhert Endowment for Urological Research and Medical Director of Chesapeake Urology Research Associates.

Location:

Towson
Physicians Pavilion North, GBMC Campus/Tulip Park
6535 N. Charles Street, Suite 500
Towson, MD 21204

Office: 410-825-5454
Fax: 410-825-5811